A bone void is a cavity in bone that results from a failure of the bone’s self- healing process. Infection, trauma, tumours, or orthopaedic treatments can all cause healthy bone tissue to be damaged or lost. A bone void filler/graft is a material used to fill a bone defect or a void to correct these conditions. Allografts, synthetic grafts, and autografts can all be used to fill bony voids.
Global Bone Void Fillers Market is estimated at $3.5 billion in 2022, is growing at a CAGR of 6%. Growing orthopaedic disorders and technological developments are the main drivers of market growth.
Rising number of bone fractures and people suffering from orthopaedic disorders to drive the bone void fillers market growth
Orthopaedic disorders are becoming more prevalent as the world’s population ages. In the U.S., ~1.5 million people are diagnosed with osteoporosis each year. Further, according to International Osteoporosis Foundation, the number of osteoporotic fractures in Europe (EU27, Switzerland and the UK) would grow by ~25% and reach 5.3 million in 2034 from 4.3 million in 2019. The demand for bone void fillers would increase as the number of fractures and the orthopaedic population increased.
Advanced products such as antibiotics-based bone void fillers to offer growth opportunities in Bone Void Fillers Market
Infection is main problem after orthopaedic procedures and may lead to serious consequences. As a result, major players are concentrating on launching bone void fillers developed in combination with antibiotics. In June 2021, Elute, Inc. received authorization from the US FDA to use its EP Granules with Tobramycin in clinical trial. The product is a resorbable bone void filler that delivers a broad-spectrum antibiotic in a local and targeted manner in the surgical treatment of bone infections following hip or knee replacements.
Explore Premium Report on Bone Void Fillers Market @ https://meditechinsights.com/global-bone-void-fillers-market/
Regional Overview: North America leads the acceptance of Bone Void Fillers Market
Geographically speaking, North America has a major market share of global bone void fillers revenues. This is mostly attributed to the huge number of orthopaedic procedures, rising aging population, and relatively higher penetration of bone void filling products in the region.
Companies adopting organic growth strategies to increase their market share
As a main growth strategy, companies in the bone void fillers market are concentrating on launching new and advanced products to gain market share.
In February 2022, Orthofix Medical launched a synthetic bioactive bone graft (Opus BA) for spine procedures.
In January 2022, Bone Solutions Inc. (BSI) launched Mg OSTEOINJECT, an injectable Magnesium-based bone void filler.
In September 2021, Orthofix Medical launched the Opus Mg Set osteoconductive scaffold, a synthetic magnesium-based bone void filler for orthopedic procedures. Opus Mg Set provides a procedure-specific solution for orthopedic fracture and trauma procedures by filling non-structural bony voids or gaps during surgery.
Competitive Landscape Analysis: Bone Void Fillers Market
Some key players operating in the global bone void fillers market include Medtronic, Graftys, DePuy Synthes Companies (JnJ), Stryker, Baxter, bioventus, Orthofix, Bone Solutions Inc., Curasan, Inc., Olympus Terumo Biomaterials Corporation, Biocomposites, Arthrex, Zimmer Biomet, Collagen Matrix, Bonesupport AB, among others.
For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.
Associate, Medi-Tech Insights
+32 498 86 80 79